| Literature DB >> 25258321 |
Jin Qi1, Lei Huo2, Yiwei Tony Zhu3, Yi-Jun Zhu4.
Abstract
ASH2L is a component of MLL complexes that confer H3K4 trimethylation. The ASH2L gene is located at 8q11-12, which is often amplified in breast cancers. We found that increased ASH2L expression, which can result from gene amplification, is often correlated with increased ERα expression in both breast cancer cell lines and primary breast cancers. Forced expression of ASH2L induced ERα expression in mammary epithelial cells, whereas depletion of ASH2L suppressed ERα expression in breast cancer cells. To understand the mechanism by which ASH2L regulates ERα expression, we identified GATA3 as the binding protein of ASH2L. ASH2L was shown to potentiate the transcriptional activity of GATA3. ASH2L was recruited to the enhancer of the ERα gene through GATA3 to promote ERα transcription. This study established that ASH2L enhances ERα expression as a coactivator of GATA3 in breast cancers.Entities:
Keywords: Breast Cancer; Estrogen Receptor; GATA Transcription Factor; Gene Regulation; Oncogene
Mesh:
Substances:
Year: 2014 PMID: 25258321 PMCID: PMC4223337 DOI: 10.1074/jbc.M114.579839
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157